Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with or without ulinastatin for prevention of postoperative delirium after laparoscopic gastro-colorectal tumor resection in elderly patients
ChiCTR1900027638Phase 4Not yet recruiting
- Sponsor
- Jinhua Hospital of Zhejiang University
- Start
- Jan 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ulinastatin in postoperative delirium (POD) (2 arms), sponsored by Jinhua Hospital of Zhejiang University. Primary endpoint: Delirium rate. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
dexmedetomidineulinastatin
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR1900027638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027638.